Shawn A. Bone



  • Wednesday, August 1, 2007
    With little time left before Congress leaves on its annual month-long August recess, several media issues have taken on a higher profile on Capitol Hill. One issue in particular, the question of what, if any, power the Food and Drug Administration should have to regulate direct-to-consumer drug advertisements, has been the subject of legislative action in...